Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Quantitative evaluation of cerebral vascular permeability using multi-slice dynamic CT.

K Nambu1, T Nariai, T Terada

  • 1Medical Engineering Research & Development Center, Medical Systems Company, TOSHIBA Corporation, Tochigi, Japan. nambu@mel.nasu.toshiba.co.jp

Acta Neurochirurgica. Supplement
|February 3, 2004
PubMed
Summary

We created new software to measure brain fluid and vessel volumes using CT scans. This method helps distinguish abnormal areas in brain tumors, aiding diagnosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Myelin and Axonal Damage in Normal-Appearing White Matter in Patients with Moyamoya Disease.

AJNR. American journal of neuroradiology·2020
Same author

Bayesian Estimation of CBF Measured by DSC-MRI in Patients with Moyamoya Disease: Comparison with <sup>15</sup>O-Gas PET and Singular Value Decomposition.

AJNR. American journal of neuroradiology·2019
Same author

Noninvasive Evaluation of CBF and Perfusion Delay of Moyamoya Disease Using Arterial Spin-Labeling MRI with Multiple Postlabeling Delays: Comparison with <sup>15</sup>O-Gas PET and DSC-MRI.

AJNR. American journal of neuroradiology·2017
Same author

Optical analysis of developmental changes in synaptic potentiation in the neonatal rat corticostriatal projection.

Neuroscience·2011
Same author

A clinical trial protocol for second line treatment of malignant brain tumors with BNCT at University of Tsukuba.

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2011
Same author

The status of Tsukuba BNCT trial: BPA-based boron neutron capture therapy combined with X-ray irradiation.

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2011

Area of Science:

  • Neuroradiology
  • Medical Imaging
  • Cerebrovascular Physiology

Background:

  • Assessing cerebral capillary permeability and fluid spaces is crucial for diagnosing brain conditions.
  • Current methods may lack the resolution or speed for detailed regional analysis.
  • Dynamic CT offers potential for quantitative assessment of the blood-brain barrier.

Purpose of the Study:

  • To develop and validate a novel software tool for quantifying regional cerebral blood-brain barrier (BBB) permeability, extracellular fluid space volume, and vascular bed volume.
  • To evaluate the feasibility and diagnostic utility of this method in patients with brain tumors.

Main Methods:

  • Development of a multi-slice dynamic CT-based software named "BBB study".
  • Utilized iodinated contrast medium for quantitative analysis.

Related Experiment Videos

  • Applied the software to four cases of brain tumor for evaluation.
  • Main Results:

    • The developed software, "BBB study", successfully measured regional permeability, extracellular fluid space, and vascular bed volume.
    • Examination time was approximately 20 minutes.
    • Generated functional maps were of sufficient quality to identify areas of irregular permeability enhancement in brain tumors.

    Conclusions:

    • The novel "BBB study" software provides a feasible and efficient method for assessing regional cerebral vascular and fluid space parameters using dynamic CT.
    • The technique demonstrates potential for differentiating abnormal vascular characteristics in brain tumors.
    • This quantitative approach may enhance the diagnostic capabilities in neuro-oncology.